Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

KRKR vs ZEPP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KRKR Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 6–4 Matrix Metrics)

KRKR Overall Winner 6-Pillar Tally: KRKR 3 – 2 ZEPP (1 Tie) Matrix Metrics: KRKR 6 – 4 ZEPP

As of Nov 20, 2026, 36Kr Holdings Inc. (KRKR) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). KRKR carries a Unified Composite Score of 45.3/100 (HOLD) at $2.56 (3.4x Forward P/E, 14.8% operating margin), whereas ZEPP carries 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin).

  • Technical & Structure Timing Caution: KRKR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.0); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KRKR vs ZEPP
KRKR NASDAQ Head-to-Head Winner
36Kr Holdings Inc. American Depositary Shares
Services-Business Services, Nec
$2.56
-3.4% 1D
Market Cap $5.2M
TTM Revenue $1.8M
Forward P/E 3.4x
Beta / 30D Vol 0.59β · 47% Vol
Unified Composite Score
45.3 / 100 HOLD
Tech 33.0 Fund 57.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.0%), weak momentum, RSI 34
RSI-14: 34.0 · SMA20: $2.80 · SMA50: $2.97
ZEPP NYSE
Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares
Electronic Computers
$2.31
-8.33% 1D
Market Cap $37.0M
TTM Revenue $276M
Forward P/E 3.1x
Beta / 30D Vol 2.12β · 68% Vol
Unified Composite Score
45.7 / 100 HOLD
Tech 63.0 Fund 38.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -25.0%), weak momentum, RSI 35
RSI-14: 35.4 · SMA20: $2.40 · SMA50: $3.21

6-Pillar Scorecard Institutional Category Breakdown (KRKR 3 – 2 ZEPP)

Columns: Metric · KRKR · ZEPP
1. Valuation Multiples ZEPP
Forward P/E 3.4x 3.1x
Trailing P/E 24.1x 3.1x
PEG Ratio N/M N/M
EV / Revenue 2.9x 0.1x
2. Growth & Scale KRKR
Revenue Growth (YoY) +33.7% +6.9%
Earnings Growth (YoY) +0.0% -68.1%
TTM Revenue (USD) $1.8M $276M
Market Cap $5.2M $37.0M
3. Profitability & Quality KRKR
Gross Margin 63.0% 38.6%
Operating Margin 14.8% -12.6%
Net Profit Margin 12.0% -15.8%
Return on Equity (ROE) 24.6% -21.2%
4. Balance Sheet & Cash Flow KRKR
Cash Generation (TTM) $281,238 EBITDA -$30M EBITDA
Cash Flow Margin 15.5% EBITDA Mgn -11.0% EBITDA Mgn
Net Cash / Leverage $10.11 Book/Sh · 24.6% ROE $11.68 Book/Sh · -21.2% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 124.3% (94th %ile)
Put/Call OI Skew Thin ADR Chain Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ZEPP
OpEx & R&D Intensity 48.2% of Rev ($872,095) 51.2% of Rev ($141M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Advertising Agencies Operator Consumer Electronics Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KRKR (6) vs ZEPP (4)
Institutional Metric KRKR ZEPP Criterion Row Edge
Market Capitalization
Scale
$5.2M $37.0M Larger Scale ZEPP
Trailing P/E Ratio
Valuation
24.1x 3.1x Lower Multiple ZEPP
Forward P/E Ratio
Valuation
3.4x 3.1x Lower Multiple ZEPP
Revenue Growth (YoY)
Growth
+33.7% +6.9% Higher Growth KRKR
Operating Margin (TTM)
Profitability
14.8% -12.6% Higher Margin KRKR
Net Profit Margin
Profitability
12.0% -15.8% Higher Margin KRKR
Return on Equity (ROE)
Capital Efficiency
24.6% -21.2% Higher ROE KRKR
52-Week Range Position
Momentum
2% ($2–$6) 0% ($2–$33) Stronger Trend KRKR
Beta / 30D Volatility
Risk Regime
0.59β · 47% Vol 2.12β · 68% Vol Lower Realized Risk KRKR
Unified Institutional Score
Composite Signal
45.3 / 100 (HOLD) 45.7 / 100 (HOLD) Higher Composite ZEPP
Trailing 12M Revenue (USD)
Operating Scale
$1.8M $276M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
63.0% 38.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 2.9x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$281,238 EBITDA ($10.11 Book/Sh · 24.6% ROE) -$30M EBITDA ($11.68 Book/Sh · -21.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KRKR +2.55 pp
KRKR: -14.06% · ZEPP: -16.61%
3M Horizon KRKR +38.69 pp
KRKR: -18.21% · ZEPP: -56.9%
6M Horizon KRKR +45.91 pp
KRKR: -31.73% · ZEPP: -77.64%
1Y Horizon KRKR +41.08 pp
KRKR: -49.31% · ZEPP: -90.39%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KRKR vs ZEPP. Trailing 12-month operating profitability (KRKR 14.8% vs ZEPP -12.6%) and valuation multiples (KRKR 3.4x vs ZEPP 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.

KRKR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.8M
Gross Margin63.0%
Op. Margin14.8%
ROE / Fwd P/E24.6% · 3.4x
ZEPP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$276M
Gross Margin38.6%
Op. Margin-12.6%
ROE / Fwd P/E-21.2% · 3.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KRKR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KRKR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ZEPP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 124.3%
IV Percentile 94th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ZEPP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KRKR Moat Profile Scale & Operating Efficiency Moat
Advertising Agencies Operator
Competes within the Advertising Agencies value chain with $5.2M market capitalization and 14.8% operating margin.
OpEx & R&D Reinvestment 48.2% of Rev ($872,095)
90D Engineering Disclosures 0 Published
ZEPP Moat Profile Cyclical / Execution-Driven Positioning
Consumer Electronics Operator
Competes within the Consumer Electronics value chain with $37.0M market capitalization and -12.6% operating margin.
OpEx & R&D Reinvestment 51.2% of Rev ($141M)
90D Engineering Disclosures 0 Published

Investor FAQ KRKR vs ZEPP Key Questions & Quantitative Answers

As of Nov 20, 2026, 36Kr Holdings Inc. (KRKR) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). KRKR carries a Unified Composite Score of 45.3/100 (HOLD) at $2.56 (3.4x Forward P/E, 14.8% operating margin), whereas ZEPP carries 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin). Technical & Structure Timing Caution: KRKR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.0); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KRKR leads the Growth & Scale pillar: KRKR posts +33.7% YoY revenue growth and +0.0% YoY earnings growth on $1.8M TTM revenue (63.0% gross margin, 14.8% operating margin), compared with ZEPP at +6.9% YoY revenue growth and -68.1% YoY earnings growth on $276M TTM revenue (38.6% gross margin, -12.6% operating margin). On trailing 12-month operating scale, KRKR generates $1.8M in USD-normalized revenue versus $276M for ZEPP. In operating R&D and SG&A reinvestment, KRKR deploys 48.2% of Rev ($872,095) (0 90-day corporate R&D disclosures) versus 51.2% of Rev ($141M) (0 disclosures) for ZEPP.

ZEPP screens cheaper on headline valuation multiples. KRKR trades at 3.4x Forward P/E, 24.1x Trailing P/E, N/M PEG, and 2.9x EV/Revenue (15.5% EBITDA margin), whereas ZEPP trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-11.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KRKR (24.6% ROE) versus ZEPP (-21.2% ROE) capital efficiency.

In options market volatility and institutional positioning, KRKR carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.59β · 47% Vol realized risk). By comparison, ZEPP carries 124.3% implied volatility (94th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.12β · 68% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares (ZEPP) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.